Allopurinol Industry (Global, China) 2015 Research Analysis and 2020...
DeepResearchReports.com announces new research report "2015 Global and China Allopurinol Industry" added to its store.(PRWeb May 29, 2015)Read the full story at http://www.prweb.com/releases/2015-global-china-allopur/market-research-report/prweb12755089.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 30, 2015 Category: Pharmaceuticals Source Type: news
Febuxostat More Effective Than Allopurinol at Usual DosesFebuxostat More Effective Than Allopurinol at Usual Doses
At commonly used doses, febuxostat was more effective than allopurinol at reducing serum uric acid in patients with gout, but allopurinol was likely underdosed. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 27, 2015 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Can Allopurinol Reduce Heart Attack Risk?Can Allopurinol Reduce Heart Attack Risk?
Dr Deane reviews and comments on a recent study looking at the association between use of allopurinol and risk for myocardial infarction. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - May 21, 2015 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news
Impact of Allopurinol on Risk of Myocardial InfarctionImpact of Allopurinol on Risk of Myocardial Infarction
How does allopurinol affect risk for myocardial infarction? Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 21, 2015 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Allopurinol Doesn't Worsen Acute Gout Attacks (CME/CE)
(MedPage Today) -- Worries that it might prove unfounded in randomized trial. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - April 10, 2015 Category: Rheumatology Source Type: news
Allopurinol Doesn?t Worsen Acute Gout Attacks (CME/CE)
(MedPage Today) -- Worries that it might prove unfounded in randomized trial. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - April 9, 2015 Category: Geriatrics Source Type: news
Allopurinol May Cut MI Risk in Gout Patients (CME/CE)
(MedPage Today) -- Reduction of 20% in myocardial infarction risk; randomized trials are now warranted. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 9, 2015 Category: Cardiology Source Type: news
Reconsidering Allopurinol for HypertensionReconsidering Allopurinol for Hypertension
Henry Black explains why we should proceed with caution when it comes to the use of allopurinol in hypertension management. Medscape Cardiology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 2, 2015 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Risk Factors for Toxicity to AllopurinolRisk Factors for Toxicity to Allopurinol
A study addresses the question: Which patients should not receive allopurinol? Medscape Rheumatology (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 3, 2014 Category: Drugs & Pharmacology Tags: Rheumatology Viewpoint Source Type: news
Comparing allopurinol and febuxostat in gout management
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2014 Category: Drugs & Pharmacology Source Type: news
allopurinol
Title: allopurinolCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/8/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 8, 2014 Category: Rheumatology Source Type: news
RheumShorts: Allopurinol; Autoantibodies in RA (CME/CE)
(MedPage Today) -- The rheumatology literature this week featured studies on allopurinol and severe cutaneous adverse reactions, the additive effects of autoantibodies on bone erosions in rheumatoid arthritis, and predicting response to methotrexate in children with juvenile idiopathic arthritis. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - August 20, 2014 Category: Rheumatology Source Type: news
RheumShorts: Allipurinol, Autoantibodies in RA (CME/CE)
(MedPage Today) -- The rheumatology literature this week featured studies on allopurinol and severe cutaneous adverse reactions, the additive effects of autoantibodies on bone erosions in rheumatoid arthritis, and predicting response to methotrexate in children with juvenile idiopathic arthritis. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 20, 2014 Category: Primary Care Source Type: news
Gout drug may reduce risk of death
In a recently to be published study in Annals of the Rheumatic Diseases, researchers have found the use of the drug allopurinol was associated with a reduced risk of death in hyperuricemic (gout) patients. The study, the first in a general population, has found the overall benefit of allopurinol on survival may outweigh the impact of rare serious adverse effects.Researchers from the Section of Rheumatology and Clinical Epidemiology at Boston University School of Medicine (BUSM) contributed to this study.Gout has been associated with an increased risk of premature death. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 26, 2014 Category: Consumer Health News Tags: Gout Source Type: news
Less than half of gout patients reach recommended treatment goal following treatment with allopurinol
AstraZeneca and Ardea Biosciences presented results from a large study of allopurinol, a treatment commonly used to lower uric acid in patients with gout. The LASSO (Long-term Allopurinol Safety Study evaluating Outcomes in gout patients) study was a multinational, 6-month, open, prospective observational study involving 1,735 patients with gout and was designed to evaluate the safety and efficacy of medically appropriate doses of allopurinol. Results of the LASSO study showed no new safety signals with allopurinol doses of approximately 300mg/day... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 31, 2013 Category: Consumer Health News Tags: Gout Source Type: news
